AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...

AMD announced its Ryzen AI Max processors at CES, ushering in a new series of AMD -based AI PCs and laptops. The chipmaker ...

AMD kicks of CES 2025 with a bang: its Ryzen AI Max processor combines discrete-level graphics with powerful AI, all ...

AMD has launched new processors for AI PCs, gaming laptops, gaming handhelds, and workstations at CES 2025 in Vegas.

AMD promised eventual “mobile gaming dominance” back in 2022, and it feels like we’re getting closer every day. Today, the ...

Razer taps into the AI hype for its latest laptop, but keeps the same 240Hz refresh rate as the previous Razer Blade 16 model ...

HSBC analysts on Wednesday downgraded AMD (NASDAQ:AMD) stock to Reduce from Buy, and nearly halved their price target to $110 from $200, citing a less competitive AI GPU roadmap.

At the top of the lineup is the Ryzen AI Max+ 395, featuring 16 CPU cores, 40 GPU cores, and support for up to 128GB of ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...